Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 13 | 0 | €815.00 | €831.01 | 1.964% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €426.85 | €450.36 | 5.509% |
| Boston Scientific | 56 | 0 | 4 | 0 | €74.50 | €78.23 | 5.012% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,025.5 | €1,087.6 | 6.052% |
| Insmed Inc. | 46 | 0 | 3 | 0 | €65.50 | €77.15 | 17.786% |
| UnitedHealth Group Inc. | 45 | 1 | 5 | 0 | €522.70 | €546.99 | 4.647% |
| Alnylam Pharmace. | 45 | 0 | 4 | 0 | €246.10 | €276.49 | 12.347% |
| Neurocrine Bioscience | 42 | 0 | 5 | 0 | €107.90 | €155.89 | 44.476% |
| Johnson & Johnson | 41 | 1 | 4 | 0 | €149.62 | €194.53 | 30.017% |
| Tenet Healthcare | 41 | 0 | 1 | 0 | €146.00 | €154.91 | 6.105% |
| HCA Holdings Inc. | 40 | 0 | 3 | 0 | €357.70 | €356.58 | -0.312% |
| Intuitive Surgical Inc | 37 | 0 | 3 | 0 | €434.05 | €414.56 | -4.491% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Edwards Lifesciences Corp. | 35 | 1 | 3 | 0 | €60.82 | €82.91 | 36.317% |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €50.50 | €83.13 | 64.616% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €68.00 | €85.00 | 25.000% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €173.70 | €180.90 | 4.147% |
| Stryker Corp. | 33 | 0 | 4 | 0 | €325.40 | €342.93 | 5.387% |
| Illumina Inc. | 33 | 4 | 3 | 0 | €117.92 | €158.42 | 34.348% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €107.00 | €126.38 | 18.112% |
| Jazz Pharmaceuticals plc | 32 | 0 | 3 | 0 | €98.66 | €183.41 | 85.906% |
| Pfizer Inc. | 31 | 4 | 6 | 0 | €26.79 | €40.73 | 52.078% |
| Thermo Fisher Scientific Inc. | 31 | 0 | 2 | 0 | €549.50 | €573.15 | 4.304% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €64.06 | €100.74 | 57.256% |
| Centene Corp. | 28 | 0 | 5 | 0 | €68.73 | €82.38 | 19.856% |